EAN 2017 – Patrick Vermersch Interview
Dr Patrick Vermersch discusses teriflunomide’s role in the treatment of multiple sclerosis, the focus of his article recently published in European Neurological Review.
View his article here.
Speaker disclosures: Consultant and/or support for research from: Novartis, Biogen, Sanofi,
Teva, Servier, Roche and Celgene.
Filmed at the 3rd Congress of the European Academy of Neurology (EAN), Amsterdam, June 2017.